Newly Diagnosed Multiple Myeloma: How Many Drugs are Enough?
A uniform treatment approach cannot be applied to all patients with multiple myeloma (MM). Clinicians must understand when to administer two-, three- or four or more drug regimens taking into consideration disease- and patient- characteristics. Illustrating how to individualize treatment plans will help educate health care providers about how to make best decisions in their own practice and improve outcomes of patients with newly diagnosed MM.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Maneuvering the Complex Web of Treatment Options for Relapsed/Refractory Multiple Myeloma
Clinicians face a difficult task of deciding who to treat, when to treat, and how to treat especially since many factors need to considered when determining the optimal multiple myeloma (MM) treatment for relapsed/refractory MM including: age, prognostic factors, comorbidities, toxicity profiles,
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation